Clinical Trial Update: How Darolutamide Plus Hormone Therapy Works for Men With Advanced Prostate Cancer in Everyday Medical Practice in Germany

View source ↗

Summary

This clinical trial update discusses using darolutamide in combination with hormone therapy for men with advanced, metastatic hormone-sensitive prostate cancer …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hormone-sensitive Prostate Cancer
• Prostate Cancer

Drugs mentioned

• NUBEQA (darolutamide) (darolutamide)

Snippet

Sponsor: Bayer | Conditions: Metastatic Hormone-sensitive Prostate Cancer (mHSPC) | Status: NOT_YET_RECRUITING